Several techniques are used to estimate whether investing in vaccines and i
mmunization is worthwhile, including cost analysis, cost-benefit analysis,
cost-effectiveness analysis, and cost-utility analysis. At least 162 publis
hed economic evaluations of vaccines have been carried out from 1969 to 199
8. They consistently show that immunization is an excellent investment - hi
ghly cost-effective and usually cost-saving - for vaccines that are current
ly recommended for universal use. Although prices of newer vaccines are hig
her than prices of traditional vaccines, they are still highly cost-effecti
ve. The World Health Organization, UNICEF, and vaccine manufacturers have d
eveloped approaches to make newer vaccines available to developing countrie
s at reduced prices. Sustainability of immunization programs (the ability o
f a country to continue its immunization program in the absence of external
support) is an increasingly important goal. However, external assistance w
ill be essential in the short term to ensure that all the world's people be
nefit fully from the new vaccines. (C) 1999 Academie des sciences/Editions
scientifiques et medicales Elsevier SAS.